These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25212883)

  • 1. Diagnosis and risk stratification in multiple myeloma.
    van de Donk NW; Sonneveld P
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):791-813. PubMed ID: 25212883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from the gene expression profiling of multiple myeloma.
    Claudio JO; Masih-Khan E; Stewart AK
    Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma--an update on diagnosis and treatment.
    Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K
    Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
    Klein B; Seckinger A; Moehler T; Hose D
    Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple myeloma].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM myeloma: A multicenter retrospective study of 134 patients.
    Castillo JJ; Jurczyszyn A; Brozova L; Crusoe E; Czepiel J; Davila J; Dispenzieri A; Eveillard M; Fiala MA; Ghobrial IM; Gozzetti A; Gustine JN; Hajek R; Hungria V; Jarkovsky J; Jayabalan D; Laubach JP; Lewicka B; Maisnar V; Manasanch EE; Moreau P; Morgan EA; Nahi H; Niesvizky R; Paba-Prada C; Pika T; Pour L; Reagan JL; Richardson PG; Shah J; Spicka I; Vij R; Waszczuk-Gajda A; Gertz MA
    Am J Hematol; 2017 Aug; 92(8):746-751. PubMed ID: 28383205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining IgM multiple myeloma.
    Owen RG; Feyler S; O'Connor SJ; Bond LR; de Tute RM; Rawstron AC
    Am J Hematol; 2011 Aug; 86(8):717; author reply 718-9. PubMed ID: 21761439
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
    Abdalla S; May PC; Garimberti E; Naresh KN
    Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene expression profiling defines a high-risk entity of multiple myeloma.
    Zhan FH; Barlogie B; John D S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):191-203. PubMed ID: 17478923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic indicators for the diagnosis of multiple myeloma.
    Greipp P;
    Oncology (Williston Park); 2004 May; 18(5):558-60. PubMed ID: 15209186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
    Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.
    Hartmann L; Biggerstaff JS; Chapman DB; Scott JM; Johnson KR; Ghirardelli KM; Fritschle WK; Martinez DL; Bennington RK; de Baca ME; Wells DA; Loken MR; Zehentner BK
    Am J Clin Pathol; 2011 Nov; 136(5):712-20. PubMed ID: 22031309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM multiple myeloma: more on a rare and heterogeneous disease.
    Cabrera Q; Chantepie S; Salaun V; Levaltier X; Troussard X; Macro M
    Am J Hematol; 2011 Aug; 86(8):717-8; author reply 718-9. PubMed ID: 21630314
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
    Rago A; Grammatico S; Za T; Levi A; Mecarocci S; Siniscalchi A; De Rosa L; Felici S; Bongarzoni V; Piccioni AL; La Verde G; Pisani F; Franceschini L; Paviglianiti AL; Caravita T; Petrucci MT; De Stefano V; Cimino G;
    Cancer; 2012 Nov; 118(22):5544-9. PubMed ID: 22786730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of P-selectin glycoprotein ligand-1 to prognosis in patients with multiple myeloma.
    Atalay F; Ateşoğlu EB; Yıldız S; Firatlı-Tuglular T; Karakuş S; Bayık M
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):164-70. PubMed ID: 25445472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
    Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
    PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.